Suchergebnisse - "Tarantino, Paolo"

PubPharm (16)

1

Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer

enthalten in: Nature communications | 2023

von Tarantino, P. | Gupta, H. | Hughes, M. | +24

ErratumIn: Nat Commun. 2023 Dec 14;14(1):8321. - PMID 38097580

2

Identifying Patterns and Barriers in OncotypeDX Recurrence Score Testing in Older Patients With Early-Stage, Estrogen Receptor-Positive Breast Cancer : Implications for Guidance and Reimbursement

enthalten in: JCO oncology practice | 2023

von Trapani, D. | Jin, Q. | Block, C. | +11

3

Metaplastic breast cancer : an all-round multidisciplinary consensus

enthalten in: European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) | 2023

von Corso, G. | Criscitiello, C. | Nicosia, L. | +21

4

Nodal positivity and systemic therapy among patients with clinical T1-T2N0 human epidermal growth factor receptor-positive breast cancer : Results from two international cohorts

enthalten in: Cancer | 2023

von Weiss, A. | Martínez-Sáez, O. | Waks, A. | +13

5

Assessment of the HER2DX Assay in Patients With ERBB2-Positive Breast Cancer Treated With Neoadjuvant Paclitaxel, Trastuzumab, and Pertuzumab

enthalten in: JAMA oncology | 2023

von Waks, A. | Ogayo, E. | Paré, L. | +20

6

Evolution of biological features of invasive lobular breast cancer : Comparison between primary tumour and metastases

enthalten in: European journal of cancer (Oxford, England : 1990) | 2023

von Trillo, P. | Sandoval, J. | Trapani, D. | +10

7

Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer : final 10-year analysis of the open-label, single-arm, phase 2 APT trial

enthalten in: The Lancet. Oncology | 2023

von Tolaney, S. | Tarantino, P. | Graham, N. | +27

CommentIn: Lancet Oncol. 2023 Mar;24(3):200-201. - PMID 36858719

8

The Dawn of the Antibody-Drug Conjugates Era : How T-DM1 Reinvented the Future of Chemotherapy for Solid Tumors

enthalten in: Cancer research | 2022

von Tarantino, P. | Tolaney, S.

CommentOn: Cancer Res. 2008 Nov 15;68(22):9280-90. - PMID 19010901

9

HER2-low inflammatory breast cancer : Clinicopathologic features and prognostic implications

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Tarantino, P. | Niman, S. | Erick, T. | +14

10

Navigating the HER2-Low Paradigm in Breast Oncology : New Standards, Future Horizons

enthalten in: Cancer discovery | 2022

von Tarantino, P. | Curigliano, G. | Tolaney, S.